Guest guest Posted December 20, 2008 Report Share Posted December 20, 2008 pediatric asthma AstraZeneca, MAP Enter Deal for Reformulated Asthma Drug MAP Pharmaceuticals Inc. has joined with London-based AstraZeneca to develop and commercialize a nebulized form of budesonide, a potential treatment for pediatric asthma that could work more quickly and at a lower dose than AstraZeneca's blockbuster asthma drug Pulmicort. http://tinyurl.com/94c37t Alana Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.